33,540 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by Massar Capital Management LP

Massar Capital Management LP purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 33,540 shares of the company’s stock, valued at approximately $1,791,000. Doximity accounts for approximately 2.0% of Massar Capital Management LP’s investment portfolio, making the stock its 17th largest position.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Hsbc Holdings PLC bought a new position in shares of Doximity during the 4th quarter valued at approximately $891,000. Stifel Financial Corp increased its stake in shares of Doximity by 4.5% in the fourth quarter. Stifel Financial Corp now owns 51,902 shares of the company’s stock worth $2,771,000 after purchasing an additional 2,228 shares in the last quarter. Tower Research Capital LLC TRC raised its position in shares of Doximity by 348.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,972 shares of the company’s stock valued at $426,000 after purchasing an additional 6,195 shares during the period. MetLife Investment Management LLC boosted its holdings in Doximity by 11.5% in the 4th quarter. MetLife Investment Management LLC now owns 72,540 shares of the company’s stock worth $3,873,000 after buying an additional 7,476 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Doximity in the 4th quarter worth $169,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on DOCS. Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $60.00 to $90.00 in a research note on Friday, February 7th. Wells Fargo & Company reaffirmed an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. KeyCorp dropped their target price on shares of Doximity from $83.00 to $70.00 and set an “overweight” rating for the company in a research report on Wednesday, April 16th. Needham & Company LLC lifted their price target on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a report on Friday, February 7th. Finally, Truist Financial dropped their price objective on shares of Doximity from $65.00 to $58.00 and set a “hold” rating for the company in a report on Thursday, April 10th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Doximity has an average rating of “Moderate Buy” and an average price target of $65.00.

Doximity Trading Down 3.9 %

Shares of DOCS opened at $51.16 on Tuesday. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The company’s fifty day simple moving average is $62.49 and its 200-day simple moving average is $55.97. The company has a market cap of $9.55 billion, a P/E ratio of 51.16, a P/E/G ratio of 4.10 and a beta of 1.41.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 37.40% of the stock is currently owned by corporate insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.